Value of anti-Epstein-Barr antibody detection in the diagnosis and management of nasopharyngeal carcinoma;INTERET DE LA RECHERCHE DES ANTICORPS SPECIFIQUES DU VIRUS D'EPSTEIN-BARR POUR LE DIAGNOSTIC ET LA SURVEILLANCE DU CARCINOME INDIFFERENCIE DU NASOPHARYNX

Bulletin du Cancer/Radiotherapie

Volumn 83, Issue 1, 1996, Pages 3-7

  Mazeron, M C ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Epstein Barr virus; nasopharyngeal cancer; serology

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN;

CONFERENCE PAPER; EPSTEIN BARR VIRUS; HUMAN; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; VIRUS INFECTION; BLOOD; CARCINOMA; HERPES VIRUS INFECTION; IMMUNOLOGY; NASOPHARYNX TUMOR; PATHOLOGY; REVIEW; SEROLOGY; TUMOR RECURRENCE; VIRUS CAPSID;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID; CARCINOMA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; SEROLOGY; TUMOR VIRUS INFECTIONS;

EID: 0029706173     PISSN: 09244212     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-4212(96)81343-0     Document Type: Conference Paper

References (29)

1. Burt RD Vaughan TL Nisperos B Swanson M Berwick MA protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians Int J Cancer 56 1994 465 467
2. Chen JY Chen CJ Liu MY Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan J Med Virol 27 1989 269 273
3. Chen JY Liu MY Hsu MM Cho SM Yang CS Use of bacterially-expressed antigen for detection of antibodies to the EBV-specific deoxyribonuclease in sera from patients with nasopharyngeal carcinoma J Virol Methods 1 1993 49 66
4. Cochet C Martel-Renoir D Grunwald V Expression of the Epstein-Barr virus immediate early gene BZLF1, in nasopharyngeal carcinoma tumor cells Virology 197 1993 358 365
5. De Turenne-TessierM Ooka T Calender A De Thé G Dailler J Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase Int J Cancer 43 1989 45 48
6. De Vathaire F Sancho-Garnier H De Thé H Prognostic value of EBV markers in the clinical managements of nasopharyngeal carcinoma (NPC): a multicenter follow-up study Int J Cancer 42 1988 176 181
7. Durda PJ Sullivan M Kieff E Pearson GR Rabin H An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen Intervirology 36 1993 11 19
8. Epstein MA Achong BG Barr YM Virus particles in cultured lymphoblasts from Burkitt's lymphoma Lancet 1 1964 702
9. Fahraeus R HuLF Ernberg Expression of Epstein-Barr virus encoded-proteins in nasopharyngeal carcinoma Int J Cancer 42 1988 329 338
10. Fahraeus R Rymo L Rhim JS Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus Nature 345 1990 447 449
11. Foong YT Cheng HM Sam CK Dillner J Hinderer W Prasad U Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma Int J Cancer 45 1990 1061 1064
12. Gorgievski-Hrisoho M Minderer W Nebel-Scgickel H Serodiagnosis of infectious mononucleosis by recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology J Clin Microbiol 28 1990 2305 2311
13. Henle G Henle W Ho Jhc Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma and other head and neck neoplasms and control groups J Nat Cancer Inst 44 1970 225 231
14. Joab I Nicolas JC Schwaab G Detection of anti-Epstein-Barr virus transactivator Zebra, in nasopharyngeal carcinoma Int J Cancer 48 1991 647 649
15. Kripalani-Joshi S Law HY Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis Int J Cancer 56 1994 187 192
16. Littler E Baylis SA Zen Y Conway MJ Mackett M Arrand JR Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins Lancet 337 1991 685 689
17. Martel-Renoir D Grunewald V Touitou R Schwaab G Joab I Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies J Gen Virol 76 1995 1401 1408
18. Pearson GR Weiland LH Neel HB Application of Epstein-Barr virus (EBV) serology to the diagnosis of north American nasopharyngeal carcinoma Cancer 51 1983 260 268
19. Raab-Traub N Flynn K The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation Cell 47 1986 883 889
20. Rea D Nicolas JC Virus d'Epstein-Barr et cancer Rev Fr Laboratoires 265 1994 79 85
21. Swerdlow SH Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease Histopathology 20 1992 373 385
22. Tan YS Cheng YC Naegele RF Henle W Glaser R Champion J Antibody responses to Epstein-Barr virus specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma Int J Cancer 30 1982 561 565
23. Uen WC Luka J Pearson GR Development of an enzyme-linked immunosorbent assay (Elisa) for detecting IgA antibodies to the Epstein-Barr virus Int J Cancer 41 1988 479 482
24. Van Grunsven WMJ Nable A Middeldorp JM Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex J Med Virol 40 1993 161 169
25. Yao QY Rowe M Morgan AJ Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralisation Int J Cancer 48 1991 45 50
26. Young LS Dawson CW Clark D Epstein-Barr virus gene expression in nasopharyngeal carcinoma J Gen Virol 69 1988 1051 1065
27. Zeng Y Pi GH Deng H Epstein-Barr virus seroepidemiology in China AIDS Res 2 1986 S7 S15
28. Zheng YM Tuppin P Hubert A Jeannel D Pan YJ De Thé G Environmental and dietary risk factors for nasopharyngeal carcinoma. A case-control study in Zangwu County Guangxi China Br J Cancer 69 1994 508 514
29. Zur Hausen H Schulte-Holthausen I Klein G EBV-ADN in biopsies of Burkitt's tumors and anaplastic carcinomas of the nasopharynx Nature 228 1970 1056 1058